Avoro Capital Advisors LLC
Q4 2022 13F-HR Holdings
Net value change ($000)
+1,278,668
(23.6%)
New positions
0
Sold out positions
3
Turnover %
0.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Horizon Therapeutics Public Ltd Co | 479,414 | 151.1% |
| MDGL | 382,055 | 383.0% |
| UTHR | 183,977 | 30.0% |
| ASND | 84,312 | 28.6% |
| BMRN | 66,560 | 22.1% |
| SRPT | 60,452 | 17.2% |
| DICE Therapeutics, Inc. | 56,996 | 261.4% |
| KYMR | 48,872 | 103.5% |
| FOLD | 47,436 | 17.0% |
| ALNY | 41,426 | 18.7% |
Top Reduces (Value $000, Stocks/ETFs)
| APLS | -142,119 | -20.6% |
| Mirati Therapeutics, Inc. | -135,929 | -35.1% |
| IOVA | -41,554 | -48.1% |
| DSGN | -13,843 | -37.3% |
| Seagen Inc. | -12,947 | -5.1% |
| BCRX | -10,136 | -8.9% |
| PMVP | -9,792 | -26.9% |
| KURA | -9,619 | -20.0% |
| RLAY | -8,948 | -100.0% |
| MARINUS PHARMACEUTICALS, INC. | -8,411 | -40.2% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|